|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/535 | |
| A61K 9/00 | |||
| A61K 9/48 | |||
| A61K 47/14 |
| (11) | Number of the document | 1054674 |
| (13) | Kind of document | T |
| (96) | European patent application number | 99907077.4 |
| Date of filing the European patent application | 1999-02-17 | |
| (97) | Date of publication of the European application | 2000-11-29 |
| (45) | Date of publication and mention of the grant of the patent | 2006-11-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US1999/003318 |
| Date | 1999-02-17 |
| (87) | Number | WO 1999/040921 |
| Date | 1999-08-19 |
| (30) | Number | Date | Country code |
| 74881 P | 1998-02-17 | US |
| (72) |
BAHAL, Surendra, M., US
MAURIN, Michael, B., US
|
| (73) |
Bristol-Myers Squibb Pharma Company,
PO Box 4000, Princeton, New Jersey 08443-4000,
US
|
| (54) | ORAL LIQUID FORMULATIONS OF BENZOXAZINONES HIV REVERSE TRANSCRIPTASE INHIBITORS |
| ORAL LIQUID FORMULATIONS OF BENZOXAZINONES HIV REVERSE TRANSCRIPTASE INHIBITORS |